Insight Molecular Diagnostics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 02/17/2026 | 11.41 M | $85.58 M | 0.00% | 35.62% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 2.81 M | $21.11 M | -0.29% | 8.79% |
| PURA VIDA INVESTMENTS, LLC | 02/13/2026 | 947.13 K | $7.10 M | 0.00% | 2.96% |
| VANGUARD GROUP INC | 01/29/2026 | 526.68 K | $3.95 M | 8.21% | 1.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 230.97 K | $1.73 M | 16.39% | 0.72% |
| BLACKROCK, INC. | 02/12/2026 | 131.36 K | $985.21 K | 49.36% | 0.41% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 77.20 K | $579.03 K | 100.00% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 72.45 K | $543.38 K | 100.00% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 61.38 K | $460.33 K | -16.26% | 0.19% |
| NORTHERN TRUST CORP | 02/17/2026 | 48.86 K | $366.44 K | 48.55% | 0.15% |
| STATE STREET CORP | 02/13/2026 | 47.75 K | $358.16 K | 14.10% | 0.15% |
| JANE STREET GROUP, LLC | 02/12/2026 | 42.47 K | $318.52 K | 100.00% | 0.13% |
| FNY INVESTMENT ADVISERS, LLC | 01/16/2026 | 40.58 K | $304.00 K | -23.54% | 0.13% |
| MORGAN STANLEY | 02/13/2026 | 35.91 K | $269.35 K | -42.27% | 0.11% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 28.35 K | $212.63 K | 100.00% | 0.09% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 26.16 K | $196.23 K | 100.00% | 0.08% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 24.14 K | $181.02 K | 115.19% | 0.08% |
| CITADEL ADVISORS LLC | 02/17/2026 | 15.65 K | $117.35 K | 32.75% | 0.05% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 13.40 K | $100.50 K | -43.22% | 0.04% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 13.06 K | $97.96 K | 100.00% | 0.04% |
| PRIVATE ADVISOR GROUP, LLC | 02/17/2026 | 10.42 K | $78.12 K | 0.00% | 0.03% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 5.00 K | $37.50 K | 0.00% | 0.02% |
| UBS GROUP AG | 01/29/2026 | 2.94 K | $22.06 K | 8.36% | 0.01% |
| ORG PARTNERS LLC | 01/14/2026 | 450 | $3.38 K | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 335 | $2.51 K | -24.89% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 250 | $1.88 K | -59.94% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 185 | $1.39 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 154 | $1.16 K | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 30 | $225 | 0.00% | 0.00% |
| PISCATAQUA SAVINGS BANK | 01/16/2026 | 25 | $187 | 0.00% | 0.00% |
| ALBION FINANCIAL GROUP /UT | 01/21/2026 | 7 | $53 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $8 | 100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/06/2026 | 1 | $8 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Insight Molecular Diagnostics Inc. institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of Insight Molecular Diagnostics Inc.. The most heavily invested institutionals were:
FNY Investment Advisers, LLC: 247,421
VANGUARD FIDUCIARY TRUST CO: 132,591
UBS Group AG: 22,751
Private Advisor Group, LLC: 10,416
Vanguard Global Advisers, LLC: 5,775
CITIGROUP INC: 815
51.98% of Insight Molecular Diagnostics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.07 M shares in the last 24 months. This purchase volume represents approximately $92.16 M in transactions.